Inside the Testa Bioprocess Innovation Center

By Flora Southey

- Last updated on GMT

Related tags Ge healthcare Sweden

Biopharma-Reporter takes you inside the recently opened Testa BioProcess Innovation Center in Uppsala, Sweden, and speaks with CEO of GE Nordics, Lotta Ljungqvist.

The Testa Center opened in August, 2018 to help academics, startups and biopharmaceutical companies develop and scale-up production. The centre is owned and operated by GE Healthcare Life Sciences as a non-profit company, but received SEK 100m in funding from the Swedish government.

At the time of launch, Sweden’s minister for entreprise and innovation, Mikael Damberg, described the centre as an impressive test bed​”. ​The Testa Center “promotes innovation, strengthens competitiveness, and will help us provide more efficient care in the future,” ​he added.

According to CEO of GE Nordics and the Testa Center, Lotta Ljungqvist​, the centre will benefit startups and SMEs by offering a “lower cost of accessing the facility and also reduced risk”.

The project is designed to support innovation in the life science community, she told us. “The ones driving innovation and new needs are really the entrepreneurs and startups…the Testa Center is a good way for us to interact with that scene,” ​she added.

Watch the video to look inside the 2,500m² centre and its four bioprocessing laboratories. 

Related news

Related products

show more

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...

Related suppliers

Follow us


View more